Novo Nordisk ramps up lobbying efforts for US obesity drug reimbursement
Over the summer, Novo Nordisk has hired law firms, lobbying companies and consultancies in the US to put public reimbursement for obesity drugs on the agenda.
Over the summer, Novo Nordisk has been more than usually active on K Street - the street in Washington known for being home to many of the largest lobbying firms, law firms, political consultants and advocacy organizations in the US.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
